Tech Company Financing Transactions
CritiTech Funding Round
CritiTech, based in Lawrence, secured $465 thousand from private investors.
Transaction Overview
Company Name
Announced On
1/20/2013
Transaction Type
Debt
Amount
$465,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
1849 East 1450 Rd. C1
Lawrence, KS 66044
USA
Lawrence, KS 66044
USA
Phone
Website
Email Address
Overview
CritiTech's Bioavailability Optimization Technology is a proven, proprietary drug micronization technology that enables a wide range of new and improved pharmaceuticals with multiple drug dosage and delivery options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Sam Campbell
Chief Financial Officer
Jeffrey Morrison
Chief Scientific Officer
Michael Baltezor
Founder
Bala Subramaniam
President
Matthew McClorey
VP - Customer Service
Richard Ramos
VP - Operations
Jahna Espinosa
VP - Operations
John Reynolds
VP - Operations
Mark Williams
Browse more venture capital transactions:
Prev: 1/20/2013: Algal Scientific venture capital transaction
Next: 1/21/2013: MasteryConnect venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs